BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

624 related articles for article (PubMed ID: 11739279)

  • 1. Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers.
    Steitz SA; Speer MY; Curinga G; Yang HY; Haynes P; Aebersold R; Schinke T; Karsenty G; Giachelli CM
    Circ Res; 2001 Dec; 89(12):1147-54. PubMed ID: 11739279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcification of human vascular cells in vitro is correlated with high levels of matrix Gla protein and low levels of osteopontin expression.
    Proudfoot D; Skepper JN; Shanahan CM; Weissberg PL
    Arterioscler Thromb Vasc Biol; 1998 Mar; 18(3):379-88. PubMed ID: 9514406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcification of vascular smooth muscle cell cultures: inhibition by osteopontin.
    Wada T; McKee MD; Steitz S; Giachelli CM
    Circ Res; 1999 Feb; 84(2):166-78. PubMed ID: 9933248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen Receptor Control of Atherosclerotic Calcification and Smooth Muscle Cell Osteogenic Differentiation.
    McRobb LS; McGrath KCY; Tsatralis T; Liong EC; Tan JTM; Hughes G; Handelsman DJ; Heather AK
    Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1127-1137. PubMed ID: 28473445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gla-rich protein acts as a calcification inhibitor in the human cardiovascular system.
    Viegas CS; Rafael MS; Enriquez JL; Teixeira A; Vitorino R; Luís IM; Costa RM; Santos S; Cavaco S; Neves J; Macedo AL; Willems BA; Vermeer C; Simes DC
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):399-408. PubMed ID: 25538207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differing calcification processes in cultured vascular smooth muscle cells and osteoblasts.
    Patel JJ; Bourne LE; Davies BK; Arnett TR; MacRae VE; Wheeler-Jones CP; Orriss IR
    Exp Cell Res; 2019 Jul; 380(1):100-113. PubMed ID: 31004580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of c1q/tumor necrosis factor-related protein-3 promotes phosphate-induced vascular smooth muscle cell calcification both in vivo and in vitro.
    Zhou Y; Wang JY; Feng H; Wang C; Li L; Wu D; Lei H; Li H; Wu LL
    Arterioscler Thromb Vasc Biol; 2014 May; 34(5):1002-10. PubMed ID: 24578384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteo/chondrocytic transcription factors and their target genes exhibit distinct patterns of expression in human arterial calcification.
    Tyson KL; Reynolds JL; McNair R; Zhang Q; Weissberg PL; Shanahan CM
    Arterioscler Thromb Vasc Biol; 2003 Mar; 23(3):489-94. PubMed ID: 12615658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transglutaminase 2 is central to induction of the arterial calcification program by smooth muscle cells.
    Johnson KA; Polewski M; Terkeltaub RA
    Circ Res; 2008 Mar; 102(5):529-37. PubMed ID: 18202319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor-alpha promotes in vitro calcification of vascular cells via the cAMP pathway.
    Tintut Y; Patel J; Parhami F; Demer LL
    Circulation; 2000 Nov; 102(21):2636-42. PubMed ID: 11085968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid hormone targets matrix Gla protein gene associated with vascular smooth muscle calcification.
    Sato Y; Nakamura R; Satoh M; Fujishita K; Mori S; Ishida S; Yamaguchi T; Inoue K; Nagao T; Ohno Y
    Circ Res; 2005 Sep; 97(6):550-7. PubMed ID: 16100044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix Gla protein metabolism in vascular smooth muscle and role in uremic vascular calcification.
    Lomashvili KA; Wang X; Wallin R; O'Neill WC
    J Biol Chem; 2011 Aug; 286(33):28715-28722. PubMed ID: 21705322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medial localization of mineralization-regulating proteins in association with Mönckeberg's sclerosis: evidence for smooth muscle cell-mediated vascular calcification.
    Shanahan CM; Cary NR; Salisbury JR; Proudfoot D; Weissberg PL; Edmonds ME
    Circulation; 1999 Nov; 100(21):2168-76. PubMed ID: 10571976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Replicative senescence of vascular smooth muscle cells enhances the calcification through initiating the osteoblastic transition.
    Nakano-Kurimoto R; Ikeda K; Uraoka M; Nakagawa Y; Yutaka K; Koide M; Takahashi T; Matoba S; Yamada H; Okigaki M; Matsubara H
    Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1673-84. PubMed ID: 19749165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone morphogenetic protein-7 inhibits vascular calcification induced by high vitamin D in mice.
    Kang YH; Jin JS; Yi DW; Son SM
    Tohoku J Exp Med; 2010 Aug; 221(4):299-307. PubMed ID: 20647695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smooth muscle cells deficient in osteopontin have enhanced susceptibility to calcification in vitro.
    Speer MY; Chien YC; Quan M; Yang HY; Vali H; McKee MD; Giachelli CM
    Cardiovasc Res; 2005 May; 66(2):324-33. PubMed ID: 15820201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation of the osteopontin gene enhances vascular calcification of matrix Gla protein-deficient mice: evidence for osteopontin as an inducible inhibitor of vascular calcification in vivo.
    Speer MY; McKee MD; Guldberg RE; Liaw L; Yang HY; Tung E; Karsenty G; Giachelli CM
    J Exp Med; 2002 Oct; 196(8):1047-55. PubMed ID: 12391016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Runx2/Cbfa1, but not loss of myocardin, is required for smooth muscle cell lineage reprogramming toward osteochondrogenesis.
    Speer MY; Li X; Hiremath PG; Giachelli CM
    J Cell Biochem; 2010 Jul; 110(4):935-47. PubMed ID: 20564193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of matrix Gla protein (MGP) in an in vitro model of vascular calcification.
    Mori K; Shioi A; Jono S; Nishizawa Y; Morii H
    FEBS Lett; 1998 Aug; 433(1-2):19-22. PubMed ID: 9738924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular calcification in chronic kidney disease.
    Jono S; Shioi A; Ikari Y; Nishizawa Y
    J Bone Miner Metab; 2006; 24(2):176-81. PubMed ID: 16502129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.